Aimei Health Technology Stock (AFJK) Dives on a Failed Merger
I'm LongbridgeAI, I can summarize articles.Aimei Health Technology (AFJK) stock plummeted nearly 50% after the SPAC announced the termination of its planned merger with United Hydrogen, which failed to close by the deadline. The deal was officially ended on July 7, 2026. Despite the failure ending over two years of negotiations, CEO Xie Junheng expressed optimism for future transactions. The stock has fallen 78% year-to-date but remains up significantly over the past 12 months.
Aimei Health Technology (AFJK) stock plummeted on Thursday after the special purpose acquisition company (SPAC) announced a merger update. The company said that it has ended its planned business combination with United Hydrogen after the deal failed to close before the required deadline. The company said it delivered a notice of termination on July 7, 2026. This made the notice effective immediately under the terms of the merger agreement first signed in June 2024, and later amended in June 2025.
4th of July Sale - 70% Off
- Unlock powerful investing tools and data-driven insights with TipRanks Premium for more confident investment decisions.
- Discover top stock picks and new investment opportunities through TipRanks' Smart Investor Newsletter.
Aimei Health Technology only said the proposed transaction was canceled because the closing did not occur by the agreement's required date. The SPAC also didn't announce a replacement deal or provide details about what led to the delay. Investors will note that the termination brings an end to more than two years of work on the proposed merger between Aimei Health Technology and United Hydrogen.
Aimei Health Technology CEO Xie Junheng said the company remains optimistic despite the failed transaction. He stated, "Although we were unable to complete the proposed business combination with United Hydrogen within the required timeframe, we remain confident in our ability to identify and execute a compelling transaction in the future." Junheng also thanked the United Hydrogen team for its work and professionalism throughout the merger process, even though it ultimately fell apart.
Aimei Health Technology Stock Movement Today
Aimei Health Technology stock was down 49.53% on Thursday, extending a 78.32% year-to-date fall. Even so, the stock was still up 139.16% over the past 12 months.
AFJK stock trading activity today was elevated, as some 88,000 shares changed hands. For comparison, the company's three-month average daily trading volume was about 22,000 shares.
Is Aimei Health Technology Stock a Buy, Sell, or Hold?
Turning to Wall Street, Aimei Health Technology lacks significant analyst coverage, likely due to its nature as a shell company with no operations. Instead, investors can turn to the TipRanks technical analysis tool for a better understanding of the shares. The Overall Consensus for AFJK stock is Sell, based on 14 Bearish, three Neutral, and five Bullish indicators.